Tocilizumab (Actemra) and Ketamine Therapy | Tovani Health
Actemra (Tocilizumab) — IL-6 receptor monoclonal antibody (RA, GCA, sJIA, CRS, COVID)
Verdict at Tovani Health
Fully compatible with KAP.
Tocilizumab and ketamine have no clinically significant interaction. Used for rheumatoid arthritis, giant cell arteritis, systemic juvenile idiopathic arthritis, CAR-T cytokine release syndrome, and severe COVID-19. The intrinsic considerations — lipid elevations, GI perforation risk, hepatotoxicity, neutropenia monitoring — belong to tocilizumab. Subcutaneous weekly or every-2-week dosing (RA, GCA); IV infusion every 4 weeks (RA).
If you take Actemra regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.
How Actemra interacts with ketamine
Tocilizumab is a humanized mAb that blocks IL-6 receptor signaling. Cleared by reticuloendothelial system. No CYP interaction with ketamine. Side note worth knowing for prescribers: IL-6 blockade can restore CYP3A4 activity that was suppressed by inflammation, sometimes lowering levels of other meds — a third-party effect, not a ketamine effect.
What we do at intake
Continue as scheduled. Tell us your last dose and recent lab work.
Bottom line
Tocilizumab and ketamine have no clinically significant interaction. Used for rheumatoid arthritis, giant cell arteritis, systemic juvenile idiopathic arthritis, CAR-T cytokine release syndrome, and severe COVID-19. The intrinsic considerations — lipid elevations, GI perforation risk, hepatotoxicity, neutropenia monitoring — belong to tocilizumab. Subcutaneous weekly or every-2-week dosing (RA, GCA); IV infusion every 4 weeks (RA).
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Actemra (Tocilizumab) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 22, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.